Beth Safirstein, MD, leads a site that was recently recognized by a top 10 pharma Sponsor as a leading U.S. enroller of diverse patients.
As the chair of the CNS CARE Council, Dr. Safirstein is one of the expert Principal Investigators who will inform the way Velocity sites shape and share best practices to reach the right patients and conduct high-quality clinical trials.
